Inato

Inato, founded in 2016 and headquartered in Paris, France, is a company developing an artificial intelligence module that matches biopharmaceutical trials to qualified testing sites around the world. Inato works in conjunction with pharmaceutical companies and Contract Research Organizations to develop a marketplace for clinical research sites around the world.

Inato has a second office located in New York. Their services have been utilized in over 75 countries, accounting for over 3,500 doctors and 2,000 testing sites. Inato's AI system utilizes the following data points:

• Patient accessibility
• Location capacity
• Doctor participation interest
• In-network sites willing to assist in patient accessibility

Inato's Anticovid Platform gathers, organizes, and analyzes all COVID-19 clinical trial data in one open-access hub. Anticovid presents these insights to hospitals and doctors at no charge to facilitate:

1. Search and access for the most up-to-date COVID-19 trial information
2. Analysis and understanding of the emerging COVID-19 clinical trial trends, so that medical professionals can participate in or support in trials.